IR情報

2020/04/07~2020/09/02

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2020
09/029,3659,5009,3409,476+0.42%546,2002兆8102億+3.17%
09/019,4159,5119,3769,436+1.85%693,0002兆7984億+3.05%
08/319,2909,3429,1819,265+1.37%723,6002兆7476億+1.49%
08/289,3009,3388,8889,140-2.75%844,1002兆7106億+0.34%
08/279,4019,4169,3509,398-0.12%296,9002兆7871億+3.34%
08/269,4129,4529,3729,409-0.05%331,1002兆7903億+3.85%
08/259,4409,5039,3659,414+0.41%555,3002兆7918億+4.32%
08/249,2929,3859,2769,376+1.06%408,1002兆7806億+4.4%
08/219,3649,3969,2669,278-0.87%712,0002兆7515億+3.73%
08/209,3159,4249,2959,359-0.75%616,6002兆7755億+4.95%
08/199,3709,4859,3569,430+0.14%792,1002兆7966億+6.09%
08/189,6209,6279,4179,417-2.02%962,6002兆7927億+6.27%
08/179,6109,6389,5599,611-0.62%629,3002兆8503億+8.7%
08/149,5429,7079,4619,671+2.74%1,062,5002兆8680億+9.91%
08/139,4989,5289,3109,413+1.3%1,021,1002兆7915億+7.55%
08/129,7009,7629,1889,292-5.29%1,544,6002兆7557億+6.56%
08/119,2269,8909,2239,811+13.74%2,951,2002兆9096億+12.91%
08/0720:30 アデュカヌマブ、アルツハイマー病治療薬としてのBLA申請が米国FDAに受理され、優先審査に指定
08/078,6888,6908,5378,626+1.03%578,4002兆5581億-0.09%
08/068,6288,6678,4898,538-1.44%523,6002兆5320億-1.07%
08/058,7608,7608,5508,663-1.01%568,2002兆5691億+0.37%
08/048,8008,9708,7338,751-0.3%629,5002兆5952億+1.45%
08/0315:30 2020年度第1四半期決算説明会資料
08/0312:30 2021年3月期第1四半期決算短信参考資料〔IFRS〕
08/0312:30 2021年3月期第1四半期決算短信〔IFRS〕(連結)
08/038,6378,8398,5058,777+3.42%889,3002兆6029億+1.75%
07/318,7108,7468,4728,487-3.38%628,7002兆5169億-1.54%
07/308,7508,8128,6808,784-0.13%359,2002兆6050億+1.82%
07/298,7858,8638,7768,795+0.11%327,4002兆6083億+2.03%
07/288,8408,8718,7538,785+0.45%443,9002兆6053億+2.04%
07/278,6368,8158,6308,746+0.05%615,0002兆5937億+1.73%
07/228,6678,7758,6408,742-0.29%462,9002兆5925億+1.77%
07/218,6088,8158,6088,767+2.54%642,9002兆6000億+2.14%
07/208,4758,5728,4548,550+0.48%372,1002兆5356億-0.35%
07/178,4898,6188,4418,509+1.97%912,9002兆5234億-0.64%
07/168,4478,5048,3128,345-1.37%947,3002兆4748億-2.5%
07/158,5688,5858,4258,461-1.79%1,064,7002兆5092億-1.21%
07/148,6258,7238,5758,615-0.28%484,7002兆5549億+0.38%
07/138,7768,7868,5048,639-0.96%823,6002兆5620億+0.56%
07/108,9488,9728,7198,723-2.51%1,134,7002兆5869億+1.41%
07/098,8509,0788,8068,948+4.84%1,695,3002兆6536億+4.01%
07/0820:30 アデュカヌマブ、アルツハイマー病治療薬として米国FDAへ生物製剤ライセンス申請完了
07/088,5198,6248,4928,535+0.48%642,1002兆5311億-0.64%
07/078,5818,5818,4518,494-1.4%456,7002兆5190億-1.2%
07/068,5428,6388,4968,615+1.12%296,6002兆5549億+0.17%
07/038,5008,5398,4298,520+1.13%380,8002兆5267億-0.85%
07/028,5368,5588,4168,425-1.44%535,9002兆4985億-1.92%
07/018,6898,7358,5208,548+0.02%596,5002兆5350億-0.31%
06/308,6688,6798,5138,546+0.13%603,0002兆5344億-0.05%
06/2917:00 投資単位の引下げに関する考え方および方針等について
06/298,6538,6948,5078,535-2.42%514,4002兆5311億+0.22%
06/268,7228,7718,6508,747+1.34%523,1002兆5940億+3.17%
06/258,5508,7208,5158,631-0.45%703,7002兆5596億+2.37%
06/248,6258,7658,5648,670+0.76%597,2002兆5712億+3.3%
06/2317:00 新株予約権証券の発行登録書の提出について
06/238,5538,6588,3618,605+1.01%667,2002兆5519億+3.08%
06/228,4538,6078,4448,519+0.2%420,0002兆5264億+2.6%
06/1917:00 当社企業価値・株主共同の利益の確保に関する対応方針(買収防衛策)の継続について
06/198,5988,5988,4368,502-0.7%951,3002兆5214億+2.89%
06/188,5738,6188,4838,562+0.07%385,5002兆5392億+4.15%
06/178,6658,6658,5308,556-1.63%637,2002兆5374億+4.62%
06/168,4618,7178,3508,698+6.58%1,035,0002兆5795億+6.95%
06/158,3308,4628,1508,161-2.51%548,1002兆4202億+0.93%
06/128,4738,4738,1688,371-1.42%1,503,8002兆4825億+3.9%
06/118,6608,7108,4828,492-4.54%1,199,9002兆5184億+5.83%
06/108,8318,9268,7778,896+0.74%615,3002兆6382億+11.46%
06/098,9298,9488,7568,831-0.89%695,5002兆6189億+11.62%
06/088,8708,9108,7498,910+1.84%1,126,5002兆6424億+13.36%
06/058,5808,7568,5558,749+1.34%702,5002兆5946億+12.17%
06/048,7508,7508,5568,633-0.87%792,4002兆5602億+11.58%
06/038,6638,8178,6258,709+1.71%836,4002兆5828億+13.43%
06/028,4898,5658,4028,563+1.34%670,7002兆5395億+12.49%
06/018,4638,5448,4148,450+0.14%838,6002兆5059億+11.48%
05/298,0928,4408,0548,438+4.82%1,974,6002兆5024億+11.75%
05/287,9068,0507,8108,050+1.71%817,0002兆3873億+6.91%
05/277,7017,9227,7017,915+2.78%725,4002兆3473億+5.11%
05/267,6987,7517,6187,701+1.6%633,9002兆2838億+2.33%
05/257,6607,6807,5587,580-0.14%341,3002兆2479億+0.58%
05/227,6627,6707,5407,591-0.93%503,3002兆2512億+0.52%
05/217,5457,7337,5137,662+1.36%666,1002兆2722億+1.46%
05/207,5327,6337,5067,559+0.93%673,9002兆2417億+0.08%
05/197,6007,6107,4127,489-0.33%890,8002兆2209億-0.91%
05/187,4697,5387,4227,514+0.8%620,7002兆2284億-0.67%
05/157,5697,5697,3957,454-0.48%724,7002兆2106億-1.45%
05/147,4557,5287,4087,490+1.11%713,8002兆2212億-0.94%
05/1316:00 2019年度決算説明会資料
05/1312:30 2019年度(2020年3月期)通期決算参考資料
05/1312:30 2020年3月期決算短信[IFRS](連結)
05/137,4717,5817,3917,408-1.71%907,8002兆1969億-1.85%
05/127,5467,6257,4777,537+1.3%583,3002兆2352億+0.04%
05/117,6007,6167,4407,440-1.38%626,4002兆2064億-1.12%
05/087,6047,6047,4137,544+1.78%1,123,3002兆2373億0%
05/077,1007,4357,1007,412+3.32%883,1002兆1981億-1.91%
05/017,4397,4987,1397,174-4.73%1,261,0002兆1275億-5.26%
04/307,6277,6547,4317,530+1.7%1,153,4002兆2331億-0.67%
04/287,2147,4047,2007,404+3.09%885,7002兆1957億-2.36%
04/277,1707,2817,0817,182+0.56%1,234,5002兆1299億-5.03%
04/247,1457,1656,9927,142+0.93%1,501,2002兆1180億-5.3%
04/237,0177,3106,9517,076-8.9%2,893,7002兆985億-5.68%
04/227,6217,7677,5237,767+0.79%768,7002兆3034億+3.89%
04/217,9167,9487,7037,706-2.65%858,7002兆2853億+3.71%
04/207,9468,0247,8807,916-1.81%746,1002兆3476億+7.12%
04/177,9998,0627,8968,062+3.13%908,4002兆3909億+9.72%
04/167,8637,9277,7987,817-1.67%675,5002兆3182億+6.78%
04/157,9307,9817,8797,950-0.33%755,5002兆3577億+8.7%
04/147,7078,0007,6647,976+4.96%953,5002兆3654億+9.07%
04/137,5557,7347,5347,599-1.17%472,1002兆2536億+3.88%
04/107,7987,8007,6057,689+0.3%874,9002兆2803億+4.98%
04/097,6097,6707,5357,666-0.16%673,9002兆2734億+4.33%
04/087,5617,7167,4057,678+2.7%901,3002兆2770億+4.26%
04/077,5407,6117,2707,476+1.19%1,036,5002兆2171億+1.34%